A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088

Conditions

• Healthy Volunteers

Interventions

• DRUG: IFB-088 (2.5-60.0mg) oral capsule
• DRUG: Placebo (2.5-60.mg) oral capsule
• DRUG: IFB-088 (15.0-50.0mg) oral capsule
• DRUG: Placebo oral (15.0-50.0mg) capsule

Sponsor

InFlectis BioScience

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]